Worldwide genomics revenue was up high-single-digits on a core basis with growth in the global beef markets offsetting weakness in China from COVID-related lab closures that continued in the quarter. As John mentioned earlier, the performance of the Food Safety business we acquired from 3M was...
Genomic services reported through the Animal Safety segment increased 11%. Growth resulted primarily from our Australia operation on increased volume in beef cattle and sheep testing resulting from improved economic conditions in these markets and newly won business. Revenues in our Lincoln lab decreased...